Platelet Factor News Today

This 19 year man is due to appear in court tomorrow in connection with amber gibsons death. scientists believe they have found what causes extremely rare blood clots in a small number of people who have had the astrazeneca covid vaccine. the team — based in cardiff and the us — has discovered that a protein in the blood is attracted to a key component of the vaccine, causing a chain reaction. astrazeneca says its considering how to apply the findings to adapt future jabs. concerns about clot...

Same time worldwide it is thought this oxford astrazeneca vaccine has saved about a million lives. scientists think they have found the trigger causing these clots and they think it is a protein in the blood known as platelet factor for being attracted to a key part of the vaccine. imagine a magnet and a piece of metal. they believe very rarely when this happens, it makes the immune system confused so it sends in antibodies to piling and attack the protein. but that can cause the clotting. the n...

2Informatic Unit, INMEDIT SAS and Faculty of Engineering, University of Cartagena, Cartagena, Colombia 3Clinica Respiratoria y de Alergias, Cartagena, Colombia 4Departamento de Investigaciones, Fundación Cardioinfantil, Bogotá, Colombia 5Research Department - CINEUMO, Fundación Neumológica Colombiana, Bogotá, Colombia 6Research Department and Specialization Program in Pulmonology, Universidad de la Sabana, Bogotá, Colombia Background: Chronic obstructive pulmonary disease (COPD) is associ...

2Luebeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany 3General Surgery Department, Tawam Hospital, SEHA, Al Ain, United Arab Emirates 4Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates 5Department of Genetics and Molecular Biology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates 6Department of Respiratory Medicine, Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emir...

As a clinical neurologist, I must balance on a daily basis the risks and benefits of interventions in often complex, high-risk situations. While these are specialised decisions about the net benefit of a particular course of action, they are the stuff of medicine in general – and of course of life, too. And it is just such a judgment that is preoccupying the minds of both scientists and the public following the news yesterday that the European Medicines Agency’s head of vaccines Marco Caval...